1 / 30
Alexis Andrew - xu65cyn
2 / 30
Alexis Andrew - l1ljm1j
3 / 30
Alexis Andrew - r81a8gs
4 / 30
Alexis Andrew - ojcmyiy
5 / 30
Alexis Andrew - bkpl9ty
6 / 30
Alexis Andrew - fsintag
7 / 30
Alexis Andrew - uktgv5y
8 / 30
Alexis Andrew - jofg1q2
9 / 30
Alexis Andrew - nvk683a
10 / 30
Alexis Andrew - u2810tk
11 / 30
Alexis Andrew - ecq72bm
12 / 30
Alexis Andrew - 2kwqf44
13 / 30
Alexis Andrew - idwwawn
14 / 30
Alexis Andrew - 84lg52r
15 / 30
Alexis Andrew - lee6swt
16 / 30
Alexis Andrew - 9v5njzx
17 / 30
Alexis Andrew - dpvfnyg
18 / 30
Alexis Andrew - m1reujt
19 / 30
Alexis Andrew - 8hqv0ck
20 / 30
Alexis Andrew - 6ni9pqm
21 / 30
Alexis Andrew - rjt7j6n
22 / 30
Alexis Andrew - mse4wa0
23 / 30
Alexis Andrew - bx374hy
24 / 30
Alexis Andrew - uy7zjxg
25 / 30
Alexis Andrew - bii3coc
26 / 30
Alexis Andrew - tjme0uc
27 / 30
Alexis Andrew - w0fpgi7
28 / 30
Alexis Andrew - bw6blaq
29 / 30
Alexis Andrew - eqxqlx5
30 / 30
Alexis Andrew - 0xmgww3


Predicting abrocitinib efficacy at week 12 based on clinical response at week 4: